Friday, November 25, 2011

Tregalizumab (BT-061) shows efficacy in Chronic Plaque Psoriasis - PipelineReview.com (press release)

Tregalizumab (BT-061) shows efficacy in Chronic speckle Psoriasis PipelineReview.com (press release) DREIEICH, Germany I Nov 24, 2011 I In its collaboration with Abbott, Biotest AG is pursuing an innovative therapeutic plan of action to treat the response disorders Rheumatoid Arthritis and Chronic Plaque Psoriasis victimization the monoclonal antibody ... Link To Article

No comments:

Post a Comment